What are Pacira BioSciences, Inc.'s profit margins?

Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.

Where do Pacira BioSciences, Inc.'s ratios come from?

Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Pacira BioSciences, Inc. PCRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	79.3%+1.7pp	79.4%+3.7pp	79.2%+4.8pp	78.2%+4.1pp	77.6%+4.5pp
Operating margin	3.3%—	2.6%—	——	——	——
Net margin	0.7%—	1%—	——	——	——
EBITDA margin	15.7%—	15.2%—	——	——	——
Free cash flow margin	18.1%-4.6pp	18.8%-6.7pp	17.3%-10.5pp	16.6%-10.2pp	22.7%-2.7pp
Returns
Return on equity	0.7%—	1%—	——	——	——
Return on assets	0.4%—	0.5%—	——	——	——
Return on invested capital	2.7%—	1.9%—	——	——	——
Efficiency
Asset turnover	0.5×+0.1×	0.5×+0.1×	0.5×+0.1×	0.4×0.0×	0.4×0.0×
Inventory turnover	1.1×-0.3×	1.1×-0.4×	1.1×-0.6×	1.2×-0.6×	1.4×-0.6×
Liquidity
Current ratio	4.7×+2.3×	4.5×+2.1×	5.3×+3.0×	2.4×-4.4×	2.4×-3.4×
Quick ratio	3.4×+1.4×	3.3×+1.3×	3.8×+1.9×	1.9×-3.8×	2×-2.8×
Cash ratio	1.3×+0.4×	1.3×+0.4×	1.4×+0.6×	1×-1.7×	0.9×-1.1×
Leverage
Debt-to-equity	0.6×+0.2×	0.6×-0.1×	0.6×+0.1×	0.5×+0.3×	0.4×+0.2×
Debt-to-assets	0.3×+0.1×	0.3×0.0×	0.3×+0.1×	0.2×+0.1×	0.2×+0.1×
Net debt / EBITDA	2.3×—	2.4×—	——	——	——
Interest coverage	1.5×—	1.1×—	——	——	——
Per Share
Book value per share	$15.98-6.9%	$15.39-8.6%	$16.36+0.7%	$16.67-4.2%	$17.16+0.4%
Valuation
Market capitalization	$942.78M-16.0%	$1.11B+28.0%	$1.16B+66.6%	$1.14B-14.3%	$1.15B-15.4%
Enterprise value	$1.21B+1.2%	$1.37B+18.9%	$1.44B+76.3%	$1.19B-4.9%	$1.22B-9.9%
Price / earnings	183.5×—	158.3×—	——	——	——
Price / sales	1.3×-0.3×	1.5×+0.3×	1.6×+0.6×	1.6×-0.3×	1.6×-0.4×
Price / book	1.4×0.0×	1.6×+0.5×	1.6×+0.7×	1.5×0.0×	1.4×-0.1×
EV / EBITDA	10.5×—	12.5×—	——	——	——
EV / sales	1.6×-0.1×	1.9×+0.2×	2×+0.8×	1.7×-0.1×	1.7×-0.3×
Free cash flow yield	14.1%-0.1pp	12.3%-8.3pp	10.7%-17.1pp	10.3%-3.6pp	13.9%+1.1pp
Earnings yield	0.5%—	0.6%—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Pacira BioSciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Pacira BioSciences, Inc.'s profit margins?: Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
Where do Pacira BioSciences, Inc.'s ratios come from?: Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.